Ridgecrest Wealth Partners’s ARK Genomic Revolution ETF ARKG Stock Holding History

Ridgecrest Wealth Partners’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,000	Closed	-$224K	–	123
2021 Q3	$224K	Hold	3,000	–	–	0.12%	106
2021 Q2	$278K	Hold	3,000	–	–	0.17%	90
2021 Q1	$266K	Buy	+3,000	New	+$298K	0.25%	72

Other funds holding ARKG

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Ridgecrest Wealth Partners's ARKG Position: Q4 2021 in Review

Ridgecrest Wealth Partners sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2021, closing a stake of 3,000 shares — an estimated $224K sold.

Ridgecrest Wealth Partners first reported a position in ARKG in Q1 2021 and held it in 3 quarters. The position peaked at $278K in Q2 2021. 462 funds tracked by Wall St. Rank hold ARKG as of Q4 2021.

Ridgecrest Wealth Partners reported no remaining ARK Genomic Revolution ETF position as of Q4 2021 after selling out during the quarter.
Ridgecrest Wealth Partners sold 3,000 ARK Genomic Revolution ETF shares in Q4 2021, an estimated $224K.
Ridgecrest Wealth Partners first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 3 quarters.
Ridgecrest Wealth Partners's ARK Genomic Revolution ETF position peaked at $278K in Q2 2021.
462 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2021.

Based on Ridgecrest Wealth Partners's 13F filing for Q4 2021, filed 19 Jan 2022.